Yunlai Xu
Papers
1
Total Citations
7
H-Index
1
About
Yunlai Xu is a leading figure in urologic oncology, with a focused expertise in minimally invasive surgical techniques for renal cancer. His research centers on optimizing robot-assisted partial nephrectomy, particularly by refining the retroperitoneal approach to treat renal tumors. In a landmark 2022 study, Xu conducted one of the largest retrospective cohort analyses of its kind, examining over 1,040 patients to determine the suitability of the retroperitoneal route for tumors of all locations. This work has been cited 7 times, establishing a critical evidence base for surgical decision-making. By demonstrating that the retroperitoneal approach can be effectively applied to a wider range of tumor sites than previously assumed, Xu has directly contributed to reducing patient morbidity and expanding the indications for nephron-sparing surgery. His rigorous, data-driven methodology provides a valuable framework for fellow surgeons and researchers seeking to advance the field of robotic urology.
Research Focus
Key Achievements
Top Papers
- 1